U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06970262) titled 'The Effects of FMT on Intestinal Microbiota and Pulmonary Microecology' on April 24.
Brief Summary: At present, carbapenem-resistant Enterobacteriaceae (CROs) infections are a global challenge. The use of antibiotics, proton pump inhibitors, and vasoconstrictors in the intensive care unit (ICU), as well as the disease state, have a significant impact on the intestinal flora and may also have a significant impact on the pulmonary microecology, which is unfavorable for the long-term prognosis of patients. The study of pulmonary microecology is currently a hot topic, but it is not clear whether intestinal flora disorders promote pulmona...